Drug Topics Newsletter

To view this email as a web page, click here.

PHARMACISTS' REPORT

Opioid Prescribing Decrease and Patient Script Abandonment Increase, According to Recent Study

Results from IQVIA Institute for Human Data Science's annual report, "Medicine Use and Spending in the U.S."

Understanding Both Sides of the Copay Accumulator Debate

At the 2019 Asembia Specialty Pharmacy Summit, Cardinal Health’s Bruce Feinberg articulates the pros and cons of copay accumulator programs.

Your pharmacy of the future

As patient needs place greater demands on PCPs, pharmacy is changing — and it means opportunities for new lines of service. This eBook contains a detailed step-by-step you can use to ready your pharmacy for the future! Download it now.

Ramucirumab Approved as Single Agent for Heptaocellular Carcinoma

New indication joins a series of single-agent and combination treatments for various cancers.

Side Effects of the Shingles Vaccines

What patients can expect after Shingrix or Zostavax injections.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.